Tested Applications
| Positive WB detected in | A549 cells, HeLa cells, HepG2 cells |
| Positive IP detected in | A549 cells |
| Positive IHC detected in | human breast cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | A549 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:3000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
10266-1-AP targets IFN-gamma R2 in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag0317 Product name: Recombinant human IFNGR2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 126-324 aa of BC003624 Sequence: WVTMPWFQHYRNVTVGPPENIEVTPGEGSLIIRFSSPFDIADTSTAFFCYYVHYWEKGGIQQVKGPFRSNSISLDNLKPSRVYCLQVQAQLLWNKSNIFRVGHLSNISCYETMADASTELQQVILISVGTFSLLSVLAGACFFLVLKYRGLIKYWFHTPPSIPLQIEEYLKDPTQPILEALDKDSSPKDDVWDSVSIIS Predict reactive species |
| Full Name | interferon gamma receptor 2 (interferon gamma transducer 1) |
| Calculated Molecular Weight | 45 kDa |
| Observed Molecular Weight | 50-55 kDa |
| GenBank Accession Number | BC003624 |
| Gene Symbol | IFNGR2 |
| Gene ID (NCBI) | 3460 |
| RRID | AB_2121709 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P38484 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Interferon-gamam (IFN-γ) is a cytokine critical for innate and adaptive immunity against viral and intracellular bacterial infections and for tumor control. Cellular responses to IFN-γ are activated through its interaction with a heterodimeric receptor consisting of two subunits, IFNGR1 and IFNGR2. IFNGR1 is the ligand-binding subunit which binds IFN-γ with high affinity, whereas IFNGR2 serves as the accessory subunit which attaches to IFN-γ with a significantly lower affinity. Two subunits bind one IFN-γ dimer. Defects in IFNGR2 are a cause of mendelian susceptibility to mycobacterial disease (MSMD), also known as familial disseminated atypical mycobacterial infection. (PMID: 17981204; 946248; 10888113)
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for IFN-gamma R2 antibody 10266-1-AP | Download protocol |
| IHC protocol for IFN-gamma R2 antibody 10266-1-AP | Download protocol |
| IP protocol for IFN-gamma R2 antibody 10266-1-AP | Download protocol |
| WB protocol for IFN-gamma R2 antibody 10266-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
I'll retrieve the citation information for catalog 10266-1-AP.IFN-gamma R2 Polyclonal antibody (10266-1-AP) has 16 total citations. Published in journals including Science, Cancer Communications, Nature Communications, Science Advances, Cell Death Discovery, Science China Life Sciences, PNAS, Cell Reports, Aging Cell, Cancer Gene Therapy, International Immunopharmacology, Mucosal Immunology, Scientific Reports, PLoS One, and Biomolecules and Biomedicine. The antibody is predominantly applied in WB and IF, and the citation fields center on tumor immunology and immune evasion (cancer immune evasion, tumor microenvironment, PD-L1/MHC-I regulation), infectious and fungal immunity, diabetic retinopathy and renal disease, glioma prognosis biomarkers, and inflammation-driven tissue regeneration.
| Species | Application | Title |
|---|---|---|
Cancer Commun (Lond) MAGE-C3 promotes cancer metastasis by inducing epithelial-mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma. | ||
Nat Commun DENR controls JAK2 translation to induce PD-L1 expression for tumor immune evasion. | ||
Sci Adv Plasma membrane nanodeformations promote actin polymerization through CIP4/CDC42 recruitment and regulate type II IFN signaling | ||
Cell Death Discov Aberrant Akt2 signaling in the RPE may contribute to retinal fibrosis process in diabetic retinopathy | ||
Sci China Life Sci Porcine GWAS identifies ACOT11 as regulator for macrophage IL-1β maturation via IFNGR2 palmitoylation
|









